AbbVie Urges ITC To Block Humira Rival Over Trade Secrets

By Dani Kass · December 20, 2021, 6:34 PM EST

AbbVie Inc. has asked the U.S. International Trade Commission to block imports of Alvotech's biosimilar version of the best-selling biologic Humira, claiming the Icelandic company has been poaching its employees and...

To view the full article, register now.